360 Participants Needed

Telehealth Education for Vaccine Hesitancy

SA
SB
SA
Overseen BySara Al-Dahir, PharmD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how telehealth education influences people's willingness to adopt preventive health strategies, such as improved nutrition and managing conditions like high blood pressure and diabetes. Participants will receive either personalized education tailored to their health risks or general wellness education through telehealth. The researchers aim to determine if personalized advice increases adherence to preventive health measures. The trial seeks individuals working or training in fields like healthcare, education, or food services, who are comfortable using telehealth technology like tablets or smartphones. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance preventive health strategies.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems to focus on education about vaccines and wellness, so it's unlikely that you would need to change your medication routine.

What prior data suggests that this telehealth education program is safe?

Research shows that telehealth education programs are generally safe and easy to manage. In the Telehealth: Wellness and Vaccination approach, one study found that virtual education for healthcare providers improved their knowledge and reduced vaccine hesitancy, with no reported negative effects. This suggests participants likely respond well to this type of education.

The TeleHealth: Wellness Only approach also uses telehealth for education. Studies have shown that telemedicine, including telehealth, helps people make health-related decisions like getting vaccinated without causing harm.

Since these programs focus on education and do not involve new medications or treatments, they are considered low-risk. Participants usually feel more informed and confident, with no significant negative effects.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how telehealth can tackle vaccine hesitancy by focusing on personalized education and preventative health strategies. Unlike traditional methods that might involve in-person consultations, these telehealth interventions offer convenience and accessibility, allowing individuals to receive tailored advice on nutrition, work-life balance, and disease prevention from the comfort of their homes. The trial also investigates whether personalized strategies focusing on individual health risks can engage patients more effectively than standard educational approaches. This could lead to more informed health decisions and improved vaccination rates.

What evidence suggests that this trial's telehealth education treatments could be effective for vaccine hesitancy?

Research has shown that telehealth education can help reduce worries about vaccines. For example, programs educating pregnant women about COVID-19 vaccines have increased their willingness to get vaccinated. Additionally, online education for healthcare workers has improved their understanding and reduced their concerns about vaccines. This trial will compare two telehealth approaches: one arm will focus on personalized preventative medicine strategies, while the other will provide standardized preventative medicine education. Both arms aim to inform participants and potentially change their views on vaccines. Although more research is needed, early results are promising for using telehealth to support health and prevention efforts.12467

Who Is on the Research Team?

SA

Sara Al-Dahir, PhD

Principal Investigator

Xavier University of Louisiana.

KH

Klaus Heyer, PhD

Principal Investigator

Nunez Community College

Are You a Good Fit for This Trial?

This trial is for adults aged 18-55 working in high-risk industries like healthcare, education, and food service. Participants should have incomplete COVID-19 or flu vaccinations, speak English, and be able to use telehealth tech. Those with severe allergies to vaccines, certain heart conditions, immunosuppressive diseases, or who've completed their COVID-19 vaccine series can't join.

Inclusion Criteria

Currently employed or seeking training in target industries such as healthcare, education, beauty, hospitality, food (culinary) and industrial plant workers
Able to use Telehealth technology via tablet, cell phone, or computer
I have not completed my COVID-19 or flu vaccinations.

Exclusion Criteria

I have been diagnosed with congestive heart failure.
I have been diagnosed with an irregular heartbeat.
Individuals with documented allergy or reaction to COVID-19 or influenza vaccine
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive telehealth interventions focusing on wellness, with one arm also receiving vaccination education and counseling

24-30 months
Minimum of 3 individual visits and group informational visits

Follow-up

Participants are monitored for vaccine completion and changes in vaccine hesitancy

1 year

What Are the Treatments Tested in This Trial?

Interventions

  • Telehealth: Wellness and Vaccination
  • TeleHealth: Wellness Only
Trial Overview The study tests a telehealth program run by clinical pharmacists focusing on wellness and vaccination education. Participants will either learn about general wellness or wellness plus vaccination over a period of up to 30 months through individual and group sessions. The goal is to see if this increases vaccine completion rates among at-risk workers.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Telehealth Arm: Personalized Preventative Medicine StrategiesExperimental Treatment1 Intervention
Group II: Telehealth Arm: Preventative Medicine EducationActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Xavier University of Louisiana.

Lead Sponsor

Trials
9
Recruited
2,700+

Published Research Related to This Trial

A survey of pharmacists in Alaska identified unmet training needs related to vaccine hesitancy, which is crucial for improving vaccine confidence and increasing vaccination rates.
An expert panel developed a tailored training program for pharmacy professionals, emphasizing adult-learning strategies and real-world examples to effectively address vaccine hesitancy among patients.
Pandemic response in Alaska: Preparing pharmacists to lead vaccination efforts.Robinson, R., Young, A., Wagner, R., et al.[2023]
A quality improvement project involving 70 participants successfully identified vaccine hesitancy (VH) using the Parent Attitudes about Childhood Vaccines survey, leading to targeted interventions.
After the intervention, 81.8% of participants who were initially hesitant about vaccines no longer showed hesitancy, indicating that routine screening and targeted interventions can significantly improve vaccine compliance (p = .004).
Vaccine Hesitancy in Rural Pediatric Primary Care.Mical, R., Martin-Velez, J., Blackstone, T., et al.[2021]
Vaccine hesitancy is recognized by the World Health Organization as a major global health threat, necessitating effective strategies to address it.
The AIMS approach (Announce, Inquire, Mirror, and Secure) is a training method for healthcare professionals that aims to improve communication with hesitant patients, fostering trust and potentially increasing vaccination rates.
The AIMS approach: regulating receptivity in patient-provider vaccine conversations.Parrish-Sprowl, J., Thomson, A., Johnson, RD., et al.[2023]

Citations

Using a Telehealth and Shared Decision-Making Model to ...The primary outcome is willingness to participate in preventative medicine strategies to prevent development of chronic medical conditions. The secondary ...
The Health Belief Model Applied to COVID-19 Vaccine ...The average vaccination hesitancy rate was reported by country, continent, sample, and year of data collection. 3. Results. 3.1. Characteristics ...
The contribution of ICTs and telemedicine to COVID-19 ...This paper explores the influence of Information and Communication Technologies (ICT) and telemedicine on COVID-19 vaccination decisions in the United States.
Integrating Digital Health Solutions with Immunization StrategiesCase studies from different regions demonstrate the effectiveness of these technologies in addressing challenges such as vaccine hesitancy, ...
and Evidence-Based, Motivational Interviewing–Oriented ...Primary outcomes included vaccine hesitancy. Secondary outcomes included vaccine readiness, confidence, trust in government, and health literacy ...
Improving Vaccine Counseling Skills Among Residents ...Unfortunately, only 40% of US pediatric residency programs reported in a survey that vaccine safety and counseling training is provided to ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security